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Abstract One candidate for the cytosolic labile iron
pool is iron(II)glutathione. There is also a widely held
opinion that an equivalent cytosolic labile heme pool
exists and that this pool is important for the intracel-
lular transfer of heme. Here we describe a study
designed to characterise conjugates that form between
heme and glutathione. In contrast to hydrated iron(II),
heme reacts with glutathione, under aerobic condi-
tions, to form the stable hematin–glutathione complex,
which contains iron(III). Thus, glutathione is clearly
not the cytosolic ligand for heme, indeed we demon-
strate that the rate of heme degradation is enhanced in
the presence of glutathione. We suggest that the
concentration of heme in the cytosol is extremely low
and that intracellular heme transfer occurs via intra-
cellular membrane structures. Should any heme inad-
vertently escape into the cytosol, it would be rapidly
conjugated to glutathione thereby protecting the cell
from the toxic effects of heme.
Keywords Heme  Hematin  Glutathione
Introduction
The labile iron pool, first proposed by Greenberg and
Wintrope (1946) plays an essential role in supplying
iron to iron–dependent enzymes and to mitochondria
for heme and iron–sulfur cluster synthesis (Hider and
Kong 2011). On the basis of a range of biochemical
and thermodynamic arguments, Williams (1982) sug-
gested that the oxidation state of cytosolic iron is
iron(II) and that its concentration falls in the range
10-7–10-6 M, a proposal supported by fluorescence
studies (Breuer et al 1995). Evidence has been
presented for the nature of this labile iron pool as
being iron(II)glutathione (Hider and Kong 2011),
GSH acting as a buffer for iron(II), maintaining iron in
the reduced state. An iron chaperone (PCBP–1) has
been demonstrated to only donate iron for cytosolic
[2Fe–2S] cluster assembly as a PCBP–1–Fe–GSH
complex, no transfer of iron occurring in the absence
of GSH. PCBP–1 apparently requires GSH to bind
iron (Patel et al 2019).
A labile heme cytosolic pool is also reported to
exist in mammalian cells (Shviro and Shaklai 1987;
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Sahini et al 1996) and as the axial iron coordination
sites of heme are unoccupied, it is conceivable that
GSH coordinates iron at one of these sites. Directly
relating to this suggestion is the finding of Shviro and
Shaklai (1987) that hematin binds GSH and that the
1:1 species is the dominant form of hematin (hematin
is [ironIII(OH) protoporphyrin IX], hemin is [ironIII(-
Cl) protoporphyrin IX]) in the cytosol of erythrocytes.
This finding was subsequently confirmed by Sahini
et al (1996) who also demonstrated that GSH binds to
hematin. These latter workers suggested that ‘‘GSH
may serve physiologically as the cytosolic ligand of
free hematin’’. In view of these observations we




Reduced glutathione was purchased from Santa Cruz
Biotechnology, L–ascorbic acid from Acros Organics,
other chemicals were from Sigma. Solvents were from
Fisher Scientific.
Spectroscopy of hematin–containing solutions
Hematin (50 lM) and glutathione (0–5 mM) were
dissolved in potassium phosphate buffer (10 mM, pH
8.0) containing potassium chloride (20 mM). The
absorbance of the hematin solutions was measured at
1 nm intervals between 550 nm and 750 nm using a
PerkinElmer UV/Vis spectrophotometer Lambda 2
coupled with Lambda25 software. The absorption
difference between 618 nm and 655 nm was plotted
against the log concentration of glutathione. The
affinity constant between GSH and hematin was
determined from this plot. The HySS2009 programme
(Alderighi et al 1999), was used to provide the
corresponding speciation plots.
Mass spectrometry
A solution of hematin (1.3 mg, 1 equiv) in dimethyl
formamide (1 mL) was mixed with a solution of
glutathione (6.1 mg, 10 equiv) in phosphate buffer
1 9 containing 20 mM of potassium chloride (pH =
7.5). The mixture was sonicated for 20 min (recorded
pH = 7.2). After 24 h, the solution was separated from
a small amount of precipitate formed. Samples for
mass spectrometry were prepared by diluting an
aliquot of the solution with 50:50 acetonitrile/wa-
ter ? 0.1% formic acid, or by adding 2–3 drops of
DMSO to the precipitate before dilution with 50:50
acetonitrile/water ? 0.1% formic acid. Samples were
directly infused into a Waters Micromass ZQ mass
spectrometer, using a 250 lL syringe. Low–resolution
mass spectrometry analyses were performed in posi-
tive (ES?) and negative (ES-) ion mode and data were
processed with MassLynx software (Waters).
Hematin stability in the presence of hydrogen
peroxide
The absorbance of the hematin and GS–hematin in
solution was measured between 575 nm and 700 nm
at 1 nm intervals using PerkinElmer UV/Vis spec-
trophotometer Lambda 2 coupled with Lambda25
software. H2O2 (1 mL) was added to the solutions to
give a final concentration of 0–25 lM and final
concentrations of 10 lM hematin and 0–2 mM glu-
tathione. The average change in absorbance at 618 nm
for hematin solutions, and 655 nm for GS–hematin
solutions were plotted against time.
Incubation of hematin and GS–hematin
with liposomes
Phosphatidylcholine from egg yolk (200 mg) was
dissolved in 40 mL chloroform in a 250 mL round
bottom flask. The mixture was reduced to dryness by
rotary evaporation. KCl (150 mM, 40 mL) buffered
with potassium phosphate (pH 8.0, 10 mM) was
added. Liposomes were incubated overnight at room
temperature with shaking (25 rpm). The resulting
multilamellar liposomes were centrifuged at 3000 rpm
for 5 min. The supernatant was aspirated and the
liposomes were resuspended in KCl (150 mM)
buffered with phosphate (pH 8.0, 10 mM). The
liposomes were washed twice and finally suspended
in phosphate buffered KCl (150 mM, 8 mL).
Phosphatidylcholine and cholesterol were dis-
solved in chloroform (40 mL) in a 1:1 molar ratio
(125.2 mg phosphatidylcholine, 74.8 mg cholesterol)
and treated as above. Phosphatidylcholine, cholesterol
and dicetyl phosphate were dissolved in a mix of
chloroform (40 mL) and ethanol (20 mL) in a 2:2:1
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molar ratio (59.2 mg phosphatidylcholine, 59.2 mg
cholesterol, 41.8 mg dicetyl phosphate) and processed
as above.
Hematin (10 lM) was dissolved in KCl (150 mM)
buffered to pH 8.0 with 10 mM phosphate, in the
presence or absence of GSH (2 mM). The mixture was
vortexed for 10 min, centrifuged at 4000 rpm for
5 min and the supernatant decanted. Triplicate solu-
tions (20 mL) of hematin ± glutathione were added
to phosphatidylcholine, phosphatidylcholine–choles-
terol, and phosphatidylcholine–cholesterol–dicetyl
phosphate liposomes, and incubated at 37 C with
shaking (225 rpm). Aliquots (4 mL) were taken after
15 min, 1 h, 2 h, and 4 h. The aliquots were cen-
trifuged at 4000 rpm for 10 min, and the supernatant
discarded. The pellets were dissolved in DMSO
(1.5 mL) by shaking (70 rpm) overnight. The result-
ing solution was centrifuged at 4000 rpm for 10 min
and the absorbance of the supernatant was recorded at
416 nm.
Hematin and GS–hematin stability in the presence
of ascorbic acid
Hematin was dissolved in KCl (20 mM) buffered with
potassium phosphate (10 mM, pH 8.0) with or without
glutathione, to a final concentration of either 10 lM or
1 lM. Solutions were vortexed for 10 min, cen-
trifuged at 4000 rpm for 10 min and supernatant
transferred to quartz cuvette. Ascorbic acid (1 mL)
was added to a final concentration of 300 lM. The
absorbance at 550 nm was monitored with time.
For conditions under either 5% oxygen or 100%
nitrogen the solutions were stirred under the relevant
gas for 30 min whereupon the cuvette was sealed.
Results
Interaction of glutathione with hematin
When glutathione (5 mM) was mixed with hematin
(20 lM) in phosphate buffer (10 mM, pH 8.0)
containing potassium chloride (20 mM), a shift in
the peak absorbance from 618 to 655 nm was observed
(Fig. 1a). This is in agreement with previous studies
(Shviro and Shaklai 1987). It is clear that, in contrast to
iron(II)glutathione, in the presence of a porphyrin ring
the favoured redox state is iron(III). This redox state
was confirmed by mass spectrometry, where in the
presence of glutathione, a new peak appeared at
923 m/z which corresponds to the [M ? H]? of GS/
hematin 1:1 conjugate (Fig. 2). This peak is present in
the samples prepared from both the reaction solution
(Fig. 2a) and the precipitate (Fig. 2b). The peak at
308 m/z (Fig. 2a) in the analysis of the reaction
solution corresponds to glutathione, i.e. [M ? H]?. A
peak at 308 m/z is not detected in the analysis of the
sample prepared from the precipitate (Fig. 2b), where
the peak at 923 m/z (corresponding to GS/hematin
Fig. 1 Absorption spectrum and speciation plot of
hematin ± glutathione. (a) Hematin was dissolved to a final
concentration of 10 lM in 10 mM phosphate buffer, 20 mM
KCl, pH 8.0 (red line) or 10 mM phosphate buffer, 20 mM KCl,
5 mM glutathione, pH 8.0 (blue line). (b) Speciation plot of
GShematin [hematin]total = 10 lM; [GSH] = 0–5 mM
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conjugate) has the highest intensity. The 923 m/z peak
corresponds to an iron(III) complex and not an iron(II)
complex (see legend of Fig. 2). This finding is in
agreement with observations made by previous work-
ers (Shviro and Shaklai 1987; Sahini et al. 1996).
Hematin (20 lM) was dissolved in varying concen-
trations of GSH (0–5 mM) and the difference in
absorption between 618 nm and 655 nm was plotted
against GSH concentration, leading to the determina-
tion of the affinity constant, Ka, 5.0 9 104 M-1. The
resulting speciation plot indicated that 99% of hematin
was coordinated by GSH under physiological condi-
tions. (Fig. 1b).
Fig. 2 LR–MS of hematin–glutathione samples prepared from
(a) the reaction solution and (b) the precipitate. Spectra have
been acquired in positive ion mode (ES?), in the range
250–1200 m/z. The net charge of the 923 species arises
from: ? 3 (Fe III), -2 (protoporphyrin IX), -1 (GSH),
and ? 1 (proton). If the redox state of iron was iron (II), the
923 species would be neutral and would not provide a mass peak
under ES? conditions. In order to provide such a peak, the Fe2?-
complex would require the addition of 2 protons, which would
no longer correspond to a 923 species
123
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GS–hematin stability in the presence of hydrogen
peroxide
The degradation of hematin in the presence and
absence of GSH (2 mM) induced by H2O2 was
monitored by the change of absorption at 618 nm.
Whereas there was a major change in absorption with
hematin alone, there was only a minor change
observed in the presence of GSH (Fig. 3), at both
5 lM and 10 lM H2O2. Clearly GSH protects hematin
from oxidative damage by H2O2.
GS–hematin partitioning into liposomes
Hematin is known to rapidly partition into lipid
bilayers, where the iron can redox cycle, resulting in
lipid peroxidation (Vincent 1989; Kumar and Bandy-
opadhyay 2005). In order to establish whether GSH
interferes with the partitioning of hematin, the GS–
hematin complex was incubated with phosphatidyl-
choline liposomes. In contrast to hematin, which
partitions rapidly (within 15 min), GS–hematin was
found to partition into the liposome bilayers at a much
slower rate (Fig. 4). Similar effects were observed
with cholesterol- and dicetyl phosphate–containing
phosphatidyl choline liposomes. Complexation of
hematin with GSH creates a bulkier hydrophilic
molecule, which contrasts markedly with the amphi-
philic planar structure of hematin (Fig. 5) and this
offers a ready explanation for the differential parti-
tioning properties of these two molecules.
GS–hematin stability in the presence of ascorbic
acid
When hematin was incubated with ascorbic acid
(300 lM) for 1 h there was virtually no change in
the visible spectrum. This contrasts with the behaviour
of GS–hematin when treated in an identical fashion. In
the latter case the peaks at 550 nm and 655 nm were
decreased. If ascorbic acid caused glutathione to
dissociate from hematin, the spectrum of either
hematin or heme should appear, but this was not the
case. Thus, the ascorbic acid- induced spectral change
Fig. 3 Degradation of hematin and GS.hematin in the presence
of H2O2 over time. (a), 5 lM H2O2, (b), 10 lM H2O2. Hematin
(10 lM) (Hematin, red cirlce) or GS.hematin (GS.hematin, blue
squares) (10 lM hematin, 2 mM glutathione) were dissolved in
10 mM phosphate buffer, 20 mM KCl, pH 8.0
Fig. 4 Effect of glutathione on hematin partitioning into
phosphatidylcholine liposomes. Hematin (10 lM) dissolved in
either; 10 mM phosphate buffer, 150 mM KCl, pH 8.0
(Hematin, red cirlce) or 10 mM phosphate buffer, 150 mM
KCl, 2 mM glutathione, pH 8.0 (GS.hematin, blue squares) and
incubated at 37 C with phosphatidylcholine liposomes
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is likely to result from oxidation and breakdown of the
porphyrin ring. The changes in absorbance at 550 nm
are presented in Fig. 6a. The process is dependent on
the presence of oxygen as no spectral changes were
observed under nitrogen (Fig. 6b). It is likely that a
redox reaction between reduced ascorbic acid and
hematin generates free radicals, which in turn leads to
the degradation of the porphyrin ring.
Discussion
This investigation was initiated on the premise that
reduced glutathione could form a 1:1 adduct with
heme in an analogous fashion to the adduct formation
with inorganic iron(II), namely iron(II)glutathione
(Hider and Kong 2011). Should it form, it would be a
strong candidate for the cytosolic labile heme pool.
However it emerged, as previously reported by others
(Shviro and Shaklai 1987; Sahini et al 1996), that
although heme reacts rapidly with glutathione, the
product is the 1:1 adduct of glutathione and hematin
which holds iron in the iron(III) oxidation state. This
renders it unlikely for glutathione to act as the heme
ligand in the cytosolic heme pool. Significantly
glutathione renders hematin more susceptible towards
oxidative degradation in the presence of physiological
levels of ascorbic acid (Fig. 6). This finding again
indicates that the GSH/hematin complex does not
function as the endogenous cytosolic protoporphyrin–
iron pool.
Heme is lipophilic and intercalates readily into
membranes; it has an intrinsic peroxidase activity and
can generate reactive oxygen species by redox cycling.
It is thus essential that intracellular heme is not
allowed to exist in an unbound state and must either be
bound to a chaperone molecule or be enclosed in
intracellular membrane structures, for instance the
endoplasmic reticulum. Heme uptake by enterocytes
has been reported to be mediated by a receptor—
mediated endocytic pathway (Gräsbeck et al 1979;
Worthington et al 2001), the absorbed heme, which
rapidly enters lysosomes (Wyllie and Kaufman 1982),
is probably not exposed to the cytoplasm. Newly
synthesised heme may also not be exposed to the
cytoplasm on leaving the mitochondria, instead
achieving transfer either by inter-organellar transport
via vesicles or by heme transfer during direct contact
between inter-organellar membranes (Severance and
Hamza 2009). In mammals the bulk of heme break-
down is achieved during the processing of aged
erythrocytes by macrophages. This process of ery-
throphagocytosis leads to the breakdown of hemoglo-
bin and the oxidation of heme in macrophage
lysosomes. The resulting iron being released into the
cytoplasm as hydrated iron(II) via the DMT–1 trans-
porter. Thus, at each of these three stages of heme
transfer, namely cell uptake, release from mitochon-
dria and macrophage breakdown there is no necessity
for heme to enter the cytosol. The transfer of heme via
an intermediate compartment would minimise the
release of cytotoxic heme into the cytoplasm and
facilitate the regulated movement of heme (Severance
and Hamza 2009). Indeed, in view of the toxic nature
of free heme it seems likely that its concentration in
the cytoplasm should be vanishing small. However, if
heme should inadvertently enter the cytoplasm; it
would be rapidly bound by glutathione and oxidised to
Fig. 5 Structure of hematin and GS.hematin. Carbon is
depicted in grey, oxygen in red, nitrogen in blue, iron in brown
and sulfur in yellow. (a)—Hematin structure, the two
hydrophilic carboxylate groups of the porphyrin ring are
positioned at one end of the ring whilst the hydrophobic vinyl
groups are at the opposite end of the planar molecule. (b)—
GS.hematin structure, with the addition of two carboxylate
groups and an amine group the complex is less hydrophobic and
more bulky when compared to the planar hematin molecule
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GS–hematin thus preventing the iron from redox
cycling in the presence of H2O2 (Fig. 3) and minimis-
ing the partitioning of hematin into membranes
(Fig. 4). Furthermore, in the presence of Vitamin C
it would be degraded probably in a manner similar to
that of heme oxygenase, the resulting breakdown
products being digested in lysosomes (Fig. 6). These
three properties will act cooperatively so minimising
the toxicity of any released heme into the cytoplasm.
Conclusion
Although glutathione is able to coordinate heme
bound iron, forming GS–hematin, the affinity of
glutathione for hematin is such that any heme or
hematin generated in the cytoplasm will be almost
totally bound to glutathione, forming a 1:1 complex.
Thus unlike the cytosolic labile iron pool where the
redox state of iron is buffered in the iron(II) state by
glutathione, in aerobic cells cytosolic heme will be
rapidly converted to hematin in the presence of
physiological levels of glutathione. It is suggested
that glutathione acts to remove any heme that has been
inadvertently released into the cytoplasm, and that in
normal circumstances there will be extremely low
levels of heme in the cytoplasm, intracellular transfer
of heme being conducted by vesicles and/or direct
contact between intracellular membranes.
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